EcoDrugPlus

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSTRUG00000010272
Gene Symbol: IMPDH2
3 Cross references
200 Possible Orthologues:

Inosine-5'-Monophosphate Dehydrogenase 1b

Ensembl ID : ENSTRUG00000014021
Gene Symbol: LOC101063819
4 Cross references
257 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSTRUG00000001313
Gene Symbol: INPP5D
4 Cross references
215 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSTRUG00000007600
Gene Symbol: LOC101074083
3 Cross references
213 Possible Orthologues:

Insulin Receptor-Like

Ensembl ID : ENSTRUG00000012281
Gene Symbol: LOC101074430
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSTRUG00000005173
Gene Symbol: LOC101063427
3 Cross references
204 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSTRUG00000015459
Gene Symbol: LOC101079603
3 Cross references
203 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSTRUG00000014627
Gene Symbol: LOC101068902
3 Cross references
206 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSTRUG00000004551
Gene Symbol: LOC101067303
3 Cross references
213 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSTRUG00000016290
Gene Symbol: LOC101075584
4 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSTRUG00000014016
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSTRUG00000000179
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).